Concentration (start) Volume (start) = Concentration (final) Volume (final) Purity & Documentation Data Sheet (277 KB) SDS (393 KB) English - EN (393 KB) Franais - FR (393 KB) Deutsch - DE (393 KB) Norwegian - NO (393 KB) Espaol - ES (393 KB) Swedish - SV (393 KB) Italian - IT (393 KB) Korean - KR (393 KB) Portuguese - PT (393 KB) Handling Instructions (2659 KB) References [1]
Before confirming a bulk API order, buyers should request and review: Certificate of Analysis (COA) for batch specifications, purity, assay, and test results SDS Safety Data Sheet or MSDS for handling, storage, shipping, and safety information GMP or cGMP supplier details where available USDMF, CEP, EU-GMP certificate, or COS availability where applicable and subject to inquiry Method of analysis or product specification sheet Batch record summary, where supplier permits Export invoice and packing documentation End-Use Declaration EUD support where required Quality, inspection, or supplier qualification records where applicable Pharmint helps buyers structure documentation requests before supplier matching
Global estimates of visual impairment: 2010
Finally, with an understanding of cellular events subsequent to NAPQI, the rationale for potential therapies like fomepizole that may prevent or attenuate hepatocyte death long after NAPQI formation will be addressed
